Dec 03, 2018
WUGEN Presents Updated Preclinical Data on Novel Allogeneic CAR-T Platform at ASH Annual Meeting
Nov 26, 2018
Tactiva Therapeutics Announces License to Oncolytic Vaccinia Virus Armed With CXCR4 Antagonist for Treatment of Ovarian Cancer
Nov 07, 2018
RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell Transfer at SITC 2018
Oct 18, 2018
Tactiva Therapeutics Co-Founder Kunle Odunsi Elected to National Academy of Medicine
Oct 01, 2018
Actinium Launches Iomab-ACT Program Offering Its Targeted, Chemo-Free, Lymphodepletion Technology as a Universal Solution to CAR-T Product Developers
Sep 26, 2018
RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intracellular Checkpoint Cbl-b in NK Cells at the 16th Annual Discovery on Target Conference
Aug 28, 2018
RXi Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
Aug 15, 2018
RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality and Persistence of T Cells and NK Cells for the Advancement of Immuno-Oncology Therapeutics for Solid Tumors
Aug 01, 2018
Torque Announces Proprietary Slipstream(TM) Platform for High-Efficiency Manufacturing of Deep-Primed T-Cell Therapies
Jun 26, 2018
IsoPlexis Announces Research Collaboration with Nektar Therapeutics
May 16, 2018
Lycera Announces Publication of Preclinical Immuno-Oncology Research, Demonstrating that Treatment with RORgamma Agonists Enhances CAR T-Cell Anti-Tumor Activity and Persistence, Resulting in Long-Lasting Anti-Tumor Memory T-Cells in an In Vivo Model
May 03, 2018
Agenus to Report First Quarter 2018 Financial Results on May 7, 2018 and Host Conference Call and Webcast
May 01, 2018
AgenTus Therapeutics to Present on Novel TCR Platform and Progress at PEGS Summit in Boston, MA
Apr 12, 2018
TCR2 Therapeutics to Present New Preclinical Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting
Dec 11, 2017
Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its Therapeutic T cells
Nov 20, 2017
ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center
Oct 23, 2017
Agenus creates New Cell Therapy subsidiary named AgenTus Therapeutics
Aug 08, 2017
RXi Pharmaceuticals Advances Immuno-Oncology Pipeline by Selecting Two sd-rxRNA Compounds for Preclinical Development and Sourcing cGMP Manufacturing
Jun 19, 2017
Complementary Preclinical Studies Published in Neuro-Oncology Demonstrate Immune Activation Mechanism of Tocagen's Toca 511 & Toca FC